Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: Rationale and design of the THERMAC trial

Elles M.F. Van De Voort*, Gerson M. Struik, Linetta B. Koppert, Adriaan Moelker, Reno Debets, Glenn Yo, Maura J.P.V. MacCo, Renata H.J.A. Sinke, Martine Franckena, Erwin Birnie, Cornelis Verhoef, Taco M.A.L. Klem

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)
40 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: Rationale and design of the THERMAC trial'. Together they form a unique fingerprint.

Medicine and Dentistry